News and Trends 23 Feb 2023
Italian life sciences fund hits €175M
Panakès Partners, an Italian venture capital firm in the life sciences sector, has closed its Purple Fund with a total…
Italy
- Latest Posts
News and Trends 16 Feb 2023
Newron reports ‘striking’ schizophrenia study results
Newron Pharmaceuticals S.p.A. has announced what it says are ‘very exciting new results’ from the first 100 randomized patients who…
News and Trends 26 Jan 2023
Orbsen Therapeutics happy with interim diabetic kidney disease study results
Orbsen Therapeutics Limited has announced what it says are encouraging headline interim results from the EU Horizon 2020-funded NEPHSTROM clinical…
News and Trends 6 Jan 2023
Beyond Biotech podcast 28: Mainz Biomed, Newron Pharmaceuticals
This week, we have two guests. We have conversations with Newron CEO, Stefan Weber, and Mainz Biomed CEO, Guido Bächler.…
ADVERTISEMENT
News and Trends 3 Jan 2023
Newron announces interim results from treatment-resistant schizophrenia trial
Newron Pharmaceuticals S.p.A. has announced what it says are “very compelling new results” from the first 100 enrolled patients to…
News and Trends 20 Dec 2022
Watch: Interview with IRBM’s Heidi Kingdon Jones
The IRBM Group is an innovative research and discovery CRO (contract research organization) working across all aspects of drug discovery…
Interview 14 Dec 2022
Sibylla Biotech: how physicists met biologists to discover new drugs
Discovering new drugs remains an inefficient, trial and error-based process. The founding team behind the Italian startup Sibylla Biotech explain…
News and Trends 2 Dec 2022
Partnership to deliver oncology workflow for 7 European hospitals
A BC Platforms (BCP) partnership that includes Finland’s Euformatics and Hungary’s Oncompass Medicine has been awarded a contract for the…
News and Trends 23 Nov 2022
Chiesi marks start of Biotech Center of Excellence for the future of medicine in Parma
An impressive crowd gathered at Chiesi Pharmaceutical Group yesterday (November 21) to mark the much-anticipated start of work at its…
News and Trends 17 Oct 2022
Italian study shows CRISPR/Cas9 deletion of Interleukin-30 reduces prostate cancer growth
Metastatic prostate cancer is a leading cause of cancer death in men worldwide. Interleukin (IL)-30, a cytokine that may perform…
ADVERTISEMENT
News and Trends 12 Sep 2022
Reveal Genomics reveals more HER2DX breast cancer validation data
Reveal Genomics, S.L. says it has received more validation of HER2DX, the world's first specialized genomic test for HER2+ breast…
News and Trends 22 Aug 2022
Santhera and ReveraGen announce first patient with Becker muscular dystrophy dosed in FDA-funded pilot study
The first patient has been dosed in a phase 2 pilot study looking at a treatment for muscular dystrophy. Santhera…
News and Trends 17 Aug 2022
New partnership delivers clinically proven products and manufacturing processes for advanced therapies
AGC Biologics has announced its partnership with supplier of human mesenchymal stem/stromal cells (hMSCs), RoosterBio Inc. The partnership, the companies…
News and Trends 28 Jul 2022
AGC Biologics announces gene therapy partnership with Altheia Science
A new development partnership between gene therapy company Altheia Sciences, which pioneers cell and gene treatments, and AGC Biologics, will…
News and Trends 25 Apr 2022
Forcefield Therapeutics Launched to Treat Heart Attacks with Protein Drugs
The startup Forcefield Therapeutics has been unveiled in the UK with €6M (£5.5M) backing from the investment firm Syncona. The…
News and Trends 21 Jan 2022
Two Gene Therapy Players Launch IPOs on Stormy Stock Market
After a drought of more than a year, the European gene therapy sector saw initial public offerings from Genenta Science…
ADVERTISEMENT
News and Trends 19 Jan 2022
Engitix Builds Liver Disease Pipeline with Series A and Drug Collaboration
With the close of its Series A round at €48M ($54M), the tissue models company Engitix has shifted its business…
News and Trends 12 Jul 2021
Sofinnova Taps into Italian Gene Therapy with Three Seed Financings
The French investor Sofinnova Partners has injected a total of €6M into three Italian gene therapy companies, cementing Italy’s reputation…
News and Trends 28 Jul 2020
Record Series A for Italian Biotech Funds Autoimmune Therapy
Italian biotech Enthera raised €28M in Series A funding to develop its drug candidate for type 1 diabetes and inflammatory…
News and Trends 11 May 2020
Italian Pharma Getting Back to Normal With Two Biotech Acquisitions
Despite the country being hard hit with Covid-19, Italian pharma seems to be getting back to business as usual with…
